Results 221 to 230 of about 317,688 (249)

Effectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19-Associated Venous Thromboembolism. [PDF]

open access: yesJ Infect Dis
Hager DN   +23 more
europepmc   +1 more source

In for a penny: An empirical study of earthquake experience and non‐pharmaceutical intervention effectiveness in the Marche region

open access: yesAnnals of Public and Cooperative Economics, EarlyView.
Abstract This study investigates whether prior exposure to natural disasters influenced individual compliance with non‐pharmaceutical interventions (NPIs), specifically lockdown measures, during the Corona Virus Infectious Disease 2019 (COVID‐19) pandemic. Focusing on the Marche region of Italy, which experienced a severe earthquake in 2016, we exploit
Vincenzo Alfano   +2 more
wiley   +1 more source

Media Trauma Hotspot Embracing Exaggerated COVID‐19 Mortality Reporting: Dilemmas and Practical Implications

open access: yesAsia Pacific Viewpoint, EarlyView.
ABSTRACT This study explored positive response hotspots for the handling capacity of the mass media during the first and second outbreaks of COVID‐19, targeting older adults aged 65 and older (71322 samples) of 250 local governments across South Korea.
Sun‐Bi Um
wiley   +1 more source

Impact of Economic Factor, Percent Vaccination, Healthcare Quality, and Population Density on Coronavirus Disease 2019 (COVID-19) Mortality Rates: A Global Analysis in 2023. [PDF]

open access: yesCureus
Kanokudom S   +8 more
europepmc   +1 more source

Artificial intelligence streamlines scientific discovery of drug–target interactions

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Drug discovery is a complicated process through which new therapeutics are identified to prevent and treat specific diseases. Identification of drug–target interactions (DTIs) stands as a pivotal aspect within the realm of drug discovery and development. The traditional process of drug discovery, especially identification of DTIs, is marked by
Yuxin Yang, Feixiong Cheng
wiley   +1 more source

Early and Sustained Asthma Control and Remission in Real‐World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC‐2

open access: yesClinical &Experimental Allergy, EarlyView.
Real‐world patients with severe eosinophilic asthma treated with benralizumab showed early and sustained improvements in symptoms. Clinically meaningful improvements began as early as one week after benralizumab initiation, regardless of previous biologic use, and further improved over the following year.
Erika Penz   +12 more
wiley   +1 more source

Coronavirus Disease 2019 (COVID-19) Vaccination and Stillbirth in the Vaccine Safety Datalink. [PDF]

open access: yesObstet Gynecol
Denoble AE   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy